Publikační činnost












            ******************************************************************************************

            * Publikační činnost pracovníků kliniky
            ******************************************************************************************


             
            Pohled do databáze evidence publikační činnosti v systému OBD [ URL "https://obd3.lf3.cuni
            verso.fpl?fname=obd_public&public_id=&public_id=361&_autor_org_podriz=2331"] .


            Ve výpisu jsou záznamy publikací s afiliací k 3. LF UK






            *=========================================================================================
            * Vybrané publikace

            *=========================================================================================
            Publikace za poslední 3 roky v odborných časopisech s IF, kde první autor zaměstnancem Rad
            kliniky:

            1.Holesta M, Weichet J, Grilli Wagnerova M, Lukavsky J, *Malikova H.
              Gadoxetate disodium, a modern hepatospecific MRI contrast agent: Indirect signs for gado
              deposition in the brain structures with signal intensities increase after intravenous ap

              Neurol India 2018;66 (IF 2.166)
            2.Malikova H, Holesta M, Fialova A, Arenbergerova M, Weichet J.
              Hypophysitis and other autoimmune complications related to immune checkpoints inhibitors

              Spectrum of imaging appearances. Neuroendocrinol Lett. 2018; 39 (3): 101-109 (IF 0.754)
            3.Malikova H, Burghardtova M, Koubska E, Mandys V, Kozak T, Weichet J.
              Secondary Central Nervous System Lymphoma: Spectrum of Morphological MRI Appearances.

              Neuropsychiatr Dis Treat. 2018 Mar 12;14: 733-740. (IF 2.198)
            4.Malikova H, Liscak R. A neurosurgeon's view: Outcome after RF-ablation for mTLE. [ URL "
              www.ncbi.nlm.nih.gov/pubmed/28864308"] Epilepsy Res. 2018, 142, 126-130. (IF 2.367)

            5.Malikova H, Holesta M: Gadolinium contrast agents – are they really safe?
              J Vasc Access, 2017; 18 (Suppl 2): 1-7. DOI: 10.5301/jva.5000713 (IF 1.535)
            6.Malikova H, Koubska E, Weichet J, Klener J, Rulseh A, Liscak R, Vojtech Z: Can morpholog

              differenciate between primary central nervous system lymphoma and glioblastoma? Cancer i
              (1):40. (IF 2.404)
            7.Malikova H, Koubska E, Vojtech Z, Weichet J, Syrucek M, Sroubek J, Rulseh A, Liscak R: L

              morphological changes after radiosurgery of brain arteriovenous malformations: an MRI st
              neurochirurgica (Wien), 2016, 158(9): 1683-1690 (IF 1.766)